This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Erber Aktiengesellschaft. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: The Innovative Contributions of Claudia Bernard: A Focus on Trichothecene Transformation
Introduction: Claudia Bernard is a prominent inventor based in Grafenwörth, Austria. She has made significant contributions to the field of enzymatic transformations, particularly focusing on trichothecenes. With a total of two patents to her name, her work plays a crucial role in advancing scientific understanding and applications in this area.
Latest Patents: Claudia's latest patents include "Trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive." These patents detail an alcohol dehydrogenase characterized by specific sequence ID numbers (2, 3, or 4), containing metal ions and a quinone cofactor. Additionally, they encompass functional variants that exhibit a sequence identity of at least 80%, with preferences for higher identity thresholds of 86% and 89%. The patents outline methods for enzymatically transforming trichothecenes, which are significant due to their impact on agriculture and food safety.
Career Highlights: Claudia is affiliated with Erber Aktiengesellschaft, where she utilizes her expertise in enzymatic transformations. Her research has positioned her as a key contributor to advancements in biochemistry and agricultural sciences.
Collaborations: In her endeavors, Claudia collaborates with notable colleagues such as Eva-Maria Binder and Barbara Weber. These partnerships enhance the quality and breadth of her research, fostering an innovative environment that catalyzes new discoveries.
Conclusion: Claudia Bernard's work exemplifies the intersection of innovation and scientific research. Her patents not only pave the way for further exploration of trichothecene transformations but also demonstrate the importance of collaboration in driving the field forward. As she continues her work at Erber Aktiengesellschaft, she remains a vital force in the world of patentable inventions.